Economic TimesLean R·
AstraZeneca's Enhertu gets CDSCO nod
AstraZeneca Pharma India Ltd on Thursday said it has received approval from India’s national drug regulatory body to import, sell and distribute its smart chemo-therapy brand Enhertu for an additional indication.The approval was granted by the Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services, Ministry of Health & Family Welfare, Govt. of India on June 10, the company said in information to the exchanges.This further allows the use of Enhe…
Read at Economic Times →
